GO
Loading...

Insurance

More

  • It's Diabetes Drug Days Wednesday, 1 Apr 2009 | 11:28 AM ET
    Pills

    An estimated 20 million or so Americans have the disease, which many experts call an epidemic. It costs this country tens of billions of dollars a year to deal with it. And several biopharma and monitoring device companies are racing to grab a bigger piece of this fast-growing, sugar-free pie.

  • Top Doctors Take Stand Against Pharma Marketing 'Swag' Tuesday, 31 Mar 2009 | 4:02 PM ET

    A prestigious peer-reviewed journal is proposing taking a hardline stance on what it calls the "pervasive" funding relationship between drug and medical device companies and professional medical associations.

  • Lilly & Amylin: Please Keep It Simple Tuesday, 31 Mar 2009 | 12:46 PM ET

    Shares of Amylin Pharmaceuticals are rallying on a press release from AMLN and its partners Eli Lilly and Alkermes that their once-a-week version of the injectable diabetes drug Byetta (buy-ate-uh) lowered blood sugar levels more than the pills Januvia from Merck and Actos from Takeda.

  • Cramer: Monday’s Dow Decline Was a ‘Gift’ Monday, 30 Mar 2009 | 7:24 PM ET

    Sure, the market saw some losses today. But that’s a good thing for investors.

  • Knocked Out Of The Arena Monday, 30 Mar 2009 | 11:27 AM ET

    There is no quid pro quo in my line of work. At least there shouldn't be. But when you do two stories on CNBC and another one on "TODAY" that mentions a company's drug and profiles a patient who appears to have been a "responder" in one of its clinical trials you expect a certain basic professional level of cooperation and assistance.

  • Genentech, Dendreon & Your Emails Friday, 27 Mar 2009 | 4:24 PM ET

    I'm on the road on assignment, but used a little downtime to go through the "Pharma's Market" mailbox. Regarding my farewell to Genentech post yesterday a couple of folks emailed to point out that GENE was Genentech's ticker symbol when it was traded on the Nasdaq back in the day. Then it was GNE on the NYSE before going to the much better DNA.

  • Goodbye Genentech & Your DNA Thursday, 26 Mar 2009 | 2:29 PM ET

    DNA has always been one of my favorite clever ticker symbols on the biopharma beat. Sure, GENE might've made sense for Genentech if it had been listed on the Nasdaq, but DNA was pretty good. But after today DNA is no more.

  • Did Dendreon Do Itself In? Wednesday, 25 Mar 2009 | 12:34 PM ET

    Oh, the Dendreon investor message boards are on fire! And my inbox has a few sparks. Matthew Herper at Forbes wrote a piece today daring to question the integrity of the all-important data due out sometime next month on DNDN's prostate cancer treatment Provenge.

  • Roll Out The Red Carpet! ASCO Goes Hollywood Tuesday, 24 Mar 2009 | 10:45 AM ET

    All of my, ahem, complaining and whining, to put it politely, about the American Society of Clinical Oncology may not have fallen on deaf ears after all.

  • Genentech & Abbott CEOs Roar Monday, 23 Mar 2009 | 3:47 PM ET
    Genetech

    Art Levinson and Miles White are "Kings of the Jungle." At least Barron's thinks they are. The weekly investment periodical picked the pair as the only two from biopharma to make its annual list of the "30 Most Respected CEOs."

  • AIG Gives Staff Deadline on Bonus Payback Decision Friday, 20 Mar 2009 | 7:16 PM ET
    Aig Headquarters

    Management at American International Group's financial products unit asked its employees to let the unit know by 5 p.m. on Monday if they plan to return all or part of the bonuses they got under an employee retention program, said the Wall Street Journal, citing a person familiar with the matter.

  • My Tweets And Your Emails Friday, 20 Mar 2009 | 4:44 PM ET

    My first week on Twitter has gone pretty well. Despite some Twitter trouble (or should that be twubble?) with website capacity, I've picked up more than 75 followers already.

  • Better Hide Your Badge, AIG Tells Employees Friday, 20 Mar 2009 | 4:43 PM ET
    Aig Headquarters

    AI G's corporate security advised employees to take measures to increase their safety and security due to "a growing sense of public attention fueled by increased media scrutiny."

  • GlaxoSmithKline's New Ally For Alli Friday, 20 Mar 2009 | 11:28 AM ET

    Normally, the folks at GlaxoSmithKline keep us tightly in the loop when there's news. So, I'm a bit surprised that it took a "tweet" on Twitter this morning to learn that four days ago the company put out a press release that has "Pharma's Market" written all over it.

  • Scorn Trails AIG Executives, Even in Their Driveways Friday, 20 Mar 2009 | 5:23 AM ET
    AIG

    The A.I.G. executive who was nicknamed “Jackpot Jimmy” by a New York tabloid walked up the driveway toward his bay-windowed house in Fairfield, Conn., on Thursday afternoon. "How do I feel?” said the executive, James Haas, repeating the question he had just been asked. “I feel horrible. This has been a complete invasion of privacy," the New York Times reported.

  • I understand that the government will pay 65 percent of my COBRA payment.  Does that mean I should only pay 35 percent of the initial payment?

  • Pfizer: Turning The Bad Economy Into Good PR? Thursday, 19 Mar 2009 | 11:01 AM ET
    Pfizer

    Pfizer announced this morning that it's raising the income levels for uninsured people to qualify for cheaper or free drugs because of the bad economy.

  • A Defining Moment for Treasury Secretary Thursday, 19 Mar 2009 | 9:34 AM ET
    Treasury Secretary Timothy Geithner

    All three of President Obama’s top economic advisers were on message when they appeared Sunday on separate television talk shows. Treasury Secretary Timothy F. Geithner, they said, had concluded, based on lawyers’ advice, that he could not stop the $165 million in bonuses that the American International Group was even then doling out to hundreds of employees.

  • Obama Officials Sought To Keep AIG Bonuses: Dodd Wednesday, 18 Mar 2009 | 7:02 PM ET
    Sen. Christopher Dodd

    In a stunning development, Sen. Christopher Dodd told CNN that Obama officials asked him to add language to last month's stimulus bill to keep AIG bonuses in place.

  • How to Get Prescription Drugs for Less Wednesday, 18 Mar 2009 | 5:46 PM ET

    Overpaying for our prescription drugs just feels like a headache no one needs right now, doesn’t it?

Contact Insurance

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More